Developing a new drug start to finish can take years — even decades — and cost billions. But, there’s a shortcut: repurposing old drugs…
Alzheimer’s is incredibly prevalent, but notoriously difficult to diagnose. Some of the most important information can only be gleaned from expensive and invasive processes,…
IBM researchers trained artificial intelligence to help predict Alzheimer’s by looking at word usage and subtle language differences in writing tests, predicting who would…
Concussions are a serious problem. With symptoms ranging from a day-or-two-long headache up to prohibitive dizziness and cognitive issues that could last for weeks,…
Despite more than a century of research since Alzheimer’s disease was first described in 1906, diagnosing Alzheimer’s remains extremely challenging for physicians. Researchers are…
Increasingly, scientists have looked to the eye for clues to Alzheimer’s. Past studies have taken all angles, from identifying links between beta-amyloid clumps in…
A noninvasive dementia sleep test may help with predicting and diagnosing neurodegenerative diseases in older adults. Sleep has been an increasing focus of study…
The occasional minor cognitive error is a perfectly normal occurrence, but some people live with persistent, subjective cognitive difficulties that have no underlying structural,…
The world is facing increasing numbers of people with Alzheimer’s and related dementias. While there is no cure for Alzheimer’s, some treatments can help…
Alzheimer’s disease affects one in 10 people over the age of 65, but testing for a definitive diagnosis is difficult. As of now, no…
Blood tests for Alzheimer’s have been in development for some time, some of which have even been shown to have a 100 percent accuracy…
Scanning technology is the most definitive way of diagnosing Alzheimer’s disease. One of the most accurate is called a positron emission tomography (PET) scan,…
As we age, so do our abilities to see and hear… Now, new research indicates that out of all of our senses, our sense…
The longstanding “amyloid hypothesis” suggests that Alzheimer’s hallmark beta-amyloid plaques and smaller clumps of beta-amyloid oligomers — proteins highly toxic to brain cells — can…
Years of study into the Alzheimer’s biomarker named beta-amyloid have yielded few notable results for an earlier diagnosis and drug treatment. As one alternative,…